본문

  1. Home
142 Results:GROW PP:ELSEVIER INC 0.156 sec.
RSS 
Multilingual
 Расширенный поиск
 Новый поиск книги прибытия
Selected Print Select Export to Excel
11
Cellular mechanisms for methotrexate chemotherapy-induced bone growth defects
Cellular mechanisms for methotrexate chemotherapy-induced bone growth defects
Xian, C. J., | Elsevier Inc | 2007 ,
12
Influence of physiological effort of growth and chemical composition on antler bone mechanical properties
Influence of physiological effort of growth and chemical composition on antler bone mechanical properties
Landete-Castillejos, T., | Elsevier Inc | 2007 ,
13
Maturity- and sex-related changes in tibial bone geometry, strength and bone???muscle strength indices during growth: A 20-month pQCT study
Maturity- and sex-related changes in tibial bone geometry, strength and bone???muscle strength indices during growth: A 20-month pQCT study
Macdonald, H. M., | Elsevier Inc | 2005 ,
14
Varying contributions of growth and ageing to racial and sex differences in femoral neck structure and strength in old age
Varying contributions of growth and ageing to racial and sex differences in femoral neck structure and strength in old age
Wang, X. F., | Elsevier Inc | 2005 ,
15
Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency
Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency
H??gler, W., | Elsevier Inc | 2005 ,
16
Differential effects of alendronate treatment on bone from growing osteogenesis imperfecta and wild-type mouse
Differential effects of alendronate treatment on bone from growing osteogenesis imperfecta and wild-type mouse
Misof, B. M., | Elsevier Inc | 2005 ,
17
Corrigendum to “A Ser250Trp substitution in mouse fibroblast growth factor receptor 2 (Fgfr2) results in craniosynostosis�? [Bone 33 (2003) 167–178]
Corrigendum to “A Ser250Trp substitution in mouse fibroblast growth factor receptor 2 (Fgfr2) results in craniosynostosis�? [Bone 33 (2003) 167–178]
Chen, L., | Elsevier Inc | 2005 ,
18
Growth hormone can reverse glucocorticoid-induced low bone turnover on cortical but not on cancellous bone surfaces in adult Wistar rats
Growth hormone can reverse glucocorticoid-induced low bone turnover on cortical but not on cancellous bone surfaces in adult Wistar rats
Ørtoft, G., | Elsevier Inc | 2005 ,
19
Investigating the role of the growth hormone–insulin-like growth factor (GH–IGF) axis as a determinant of male bone mineral density (BMD)
Investigating the role of the growth hormone–insulin-like growth factor (GH–IGF) axis as a determinant of male bone mineral density (BMD)
Patel, M. B., | Elsevier Inc | 2005 ,
20
Prostaglandin-dependent activation of ERK mediates cell proliferation induced by transforming growth factor β in mouse osteoblastic cells
Prostaglandin-dependent activation of ERK mediates cell proliferation induced by transforming growth factor β in mouse osteoblastic cells
Ghayor, C., | Elsevier Inc | 2005 ,
처음이전12345678910이후마지막